Kamada KMDA
NASDAQ KMDA
$8.63 -0.07 (-0.76%)
As of: Sep 30, 2026 · 10:10 AM EDT

Kamada (KMDA) Operating Income (2012 - 2026)

Updated

Kamada (KMDA) recorded Operating Income of $9.51 million in the quarter ended Jun 30, 2026, up 34.5% from $7.07 million a year earlier and up 36.8% from the prior quarter.

Analysis

Kamada (KMDA) Operating Income (2012 - 2026) Analysis & Trends

On a TTM basis, Kamada's Operating Income came in at $27.83 million as of Jun 30, 2026, up 10.3% year-over-year; for the year ended Dec 31, 2025, it came in at $26.23 million, up 30.8% from the prior year.

  • Annual Operating Income has increased for three straight years, with a five-year compound annual growth rate of 6.4% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Operating Income came in at $20.05 million in the year ended Dec 31, 2024 (+99.2%), $10.06 million in the year ended Dec 31, 2023 (+122.1%), $4.53 million in the year ended Dec 31, 2022 and -$696,000 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Operating Income since the quarter ended Dec 31, 2018.
  • On a year-over-year basis, Operating Income rose in six of the last eight quarters, with growth averaging 33.0%.
  • Peak year-over-year performance for Operating Income in the last five years was growth of 114.4% in the quarter ended Jun 30, 2024, against a decline of 89.6% in the quarter ended Mar 31, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.95 million (quarter ended Mar 31, 2026), $3.55 million (quarter ended Dec 31, 2025) and $7.82 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 9.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.51 Mn
Mar 31, 2026 6.95 Mn
Dec 31, 2025 3.55 Mn
Sep 30, 2025 7.82 Mn
Jun 30, 2025 7.07 Mn
Mar 31, 2025 7.80 Mn
Dec 31, 2024 5.08 Mn
Sep 30, 2024 5.29 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 2.78 Mn
Sep 30, 2023 4.37 Mn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 289,000.00
Dec 31, 2022 4.02 Mn
Sep 30, 2022 2.56 Mn
Jun 30, 2022 -2.29 Mn
Mar 31, 2022 246,000.00
Dec 31, 2021 -3.30 Mn
Sep 30, 2021 -804,000.00
API Access

Kamada Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=KMDA&period=max&api_key=YOUR_API_KEY